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Objectives: The characterization of Bacteroides strains with regard to the cfxA gene, the MTn4555 mobilizable
transposon, the role of penicillin-binding proteins (PBPs) and heterogeneous cefoxitin resistance.
Methods: Eighty-four randomly selected and 11 heterogeneously or highly cefoxitin-resistant Bacteroides iso-
lates were included. Agar dilution and Etest methods were used for the determination of cefoxitin MICs. PCR
experiments and nucleotide sequencing were used to detect the cfxA gene and the molecular features of
MTn4555. Cefoxitin-binding experiments to determine its affinity (IC50) for PBPs and cefoxitinase assays were
also applied. Southern blotting was used to determine the copy number of the cfxA genes.
Results: Sixteen strains from the random collection proved to be positive for cfxA, and the MIC distribution for
the cfxA-negative and -positive strains did not display a clear separation. The majority of the cfxA-positive
strains in this collection harboured a 1.2 kb common region at the 3′ end of MTn4555. This region encoded
an open reading frame that exhibited homology to abortive phage infection proteins (AbiD). The cfxA genes
were transferable only at low frequencies in conjugation experiments. In PBP affinity studies, the PBP-A and
PBP3 species were largely insensitive to cefoxitin, whereas the other PBP species were affected at very low con-
centrations. Seven of the heterogeneously resistant strains were positive for cfxA and most of them had
mutations in the regulatory regions of cfxA.
Conclusions: Major and minor roles for Bacteroides fragilis PBPs and the CfxA cefoxitinase, respectively, were
inferred. The role of the newly recognized abiD may be to control the copy number of cfxA.
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Introduction
Bacteroides species are the most important anaerobic pathogens
with regard to the frequency of their isolation, their antibiotic
resistance rates and their various mechanisms of resistance.
They cause a wide variety of soft tissue infections (some of
which are life-threatening), such as abdominal, pelvic and brain
abscesses and sepsis, where Bacteroides fragilis is the most fre-
quently encountered and the most virulent species.1
The cephamycins are a good option for the treatment of
these infections. These drugs (cefoxitin, cefotetan and cefmeta-
zole) are cephalosporins whose usefulness is based on the
specific 7a-methoxy modification of their b-lactam ring, which
makes them fairly resistant to the action of most b-lactamases
and furnishes them with a lower binding capacity for penicillin-
binding proteins (PBPs).2 Only the C and B molecular type
b-lactamases are capable of readily hydrolysing them.3
While low resistance rates were reported among the B. fragilis
group strains in the 1980s (2%), moderate levels emerged in the
1990s both in Europe and in the USA (3%–7.9%).4–6 This trend
was still observed in Europe in the late 2000s (17.2%),7 but the
level of resistance seems to be decreasing in the USA in the
2000s (12% versus 9%), presumably due to the removal of
cefoxitin from clinical use.8,9
In the 1980s, the lack of known cefoxitin-degrading Bacter-
oides b-lactamases directed attention to PBPs as a possible
cause of resistance. However, strains with transferable cefoxitin
resistance were also found.10 The role of PBPs was determined
in cephalosporin resistance, including cefoxitin, in clinical
Bacteroides strains, and was also determined in cefoxitin and
piperacillin resistance using cefoxitin-resistant mutants.11 These
initial experiments, carried out with [14C]benzylpenicillin and
fluorography, revealed four to seven PBP species.12,13 A more
accurate detection of the PBP species of B. fragilis was achieved
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by exploiting the simple use of the fluorescent penicillin ana-
logue, bocillin-FL. This was facilitated by the assignments of
the genes of PBP species in clusters of orthologous groups in
the genome of B. fragilis NCTC 9343. Thus, in a recent study,
nine PBP species (A, 1ab, 1c, D, 2, 2x, 3, 4 and 7) were identified
in B. fragilis.14
The transferable cefoxitin resistance phenotype was identified
as being due to a class A b-lactamase in the 1990s. Its gene,
cfxA, has been cloned and sequenced, and demonstrated to be
localized on a mobilizable transposon, MTn4555.15,16 The nucleo-
tide sequence and functions participating in the excision, inte-
gration (int, xis and tnpC) and mobility (mobA) of MTn4555
were soon characterized.17–19 Our own investigations on the imi-
penem resistance of Bacteroides demonstrated an insertion
sequence (IS) element, IS943, which had homology to the
orf-9 of MTn4555, and this part was later proved to be an IS
element, ISBf8.20,21 A recent study identified a correlation
between the b-lactamase activity levels and the upstream
regions, which mainly differed in IS content (ISBf8 of MTn4555
or IS614B), of the cfxA genes of some Bacteroides isolates, and
also showed that cfxA genes may have multiple copies in the
harbouring strains and that these copies may sometimes be
variants.22
The roles of the two above-mentioned resistance mechanisms
that participate in the cephamycin resistance of Bacteroides have
been investigated only separately; thus, an estimation of their
overall contributions was timely. In order to gain information on
this and to acquire more data on these resistance mechanisms,
we examined CfxA and PBP-mediated cefoxitin resistance of
Bacteroides strains. Additionally, we recognized a subgroup of
Bacteroides strains that displayed heterogeneous resistance to
cefoxitin and, in light of the available data, we attempted to
elucidate how this peculiar phenotype might develop.
Materials and methods
Bacterial isolates and cultivation
Ninety-five isolates belonging to the Bacteroides genus (81 B. fragilis,
6 Bacteroides thetaiotaomicron, 4 Bacteroides ovatus, 3 Bacteroides
uniformis and 1 Bacteroides vulgatus) were analysed. They were
collected in Hungary and were selected either randomly from a larger
collection to be examined for the above-mentioned mechanisms of
cefoxitin resistance (n¼84), or were those exhibiting high or hetero-
geneous resistance to cefoxitin from an antibiotic susceptibility survey
focusing on the efficacy of tigecycline (n¼11).23 Species identification
was performed by routine methods.24 The strains were stored at
2708C in CryoBank vials (Mast Diagnostica, Rheinfeld, Germany) and
were cultivated at 378C anaerobically on Columbia agar supplemented
with 5% (v/v) blood, 5 g/L haemin and 1 g/L vitamin K1, in Wilkins–
Chalgren (WC) broth or in BHIS broth [i.e. brain heart infusion broth
supplemented with 0.5% (w/v) yeast extract, 5 g/L haemin and 1 g/L
vitamin K1], either in an anaerobic cabinet under a gas composition
of 85% N2/10% H2/5% CO2 or in jars, using gas-generating sacs
(Oxoid), for 24 h (for BHIS and WC broth) or 48 h.
The susceptibilities of the strains to cefoxitin were determined either
by agar dilution or by Etest methods, as recommended by the CLSI or the
supplier, respectively, with B. fragilis ATCC 25285 and B. vulgatus CLA341
as control strains. For resistance categorization, the CLSI breakpoints
were used.25 B. vulgatus CLA341 and B. fragilis 638R were used in PCR
experiments as positive and negative controls, respectively. B. fragilis
638R was the host strain in conjugation experiments, which were
carried out as described previously.26 The conjugative transfer of
MTn4555 was induced by the addition of 1 mg/L tetracycline to cultures
incubated overnight.
Population analysis profiles (PAPs) were recorded on WC agar plates
containing the appropriate dilution of cefoxitin by the plating of parallel
10-fold dilutions of a BHIS culture of Bacteroides strains grown for 16 h.
Cefoxitin binding competition and cefoxitinase assays
Selected B. fragilis strains in 85 mL of WC broth were grown until the
stationary phase. Cells were collected by centrifugation (JS25.5 rotors,
8000 rpm, 48C, 10 min) and resuspended in 7 mL of ice-cold PBS buffer.
The suspensions were passed twice through a French press (11000 lb/
inch2) in a cold room and the remaining debris was removed by centrifu-
gation (JS25.5 rotors, 8000 rpm, 48C, 5 min). The membrane vesicles
(2×3 mL) were collected by ultracentrifugation (Beckman TL100,
TLA-100.3 rotor, 70000 rpm, 48C, 15 min) and resuspended in either
250 or 500 mL of ice-cold PBS. The protein concentrations of the prep-
arations were determined spectrophotometrically (DC Protein Assay,
Bio-Rad).
For the inhibition of interfering b-lactamase activities, we used clavu-
lanic acid and EDTA at concentrations that inhibited the action of
b-lactamases on nitrocefin for ≥30 min.
Membrane preparations with a protein content of 60 mg were incu-
bated with the titrated amount of clavulanic acid or EDTA in 30 mL
volumes at 378C for 30 min. Cefoxitin dilutions in 10 mL were added,
giving final concentrations of 0, 0.25, 1, 4, 16, 64 and 256 mg/L cefoxitin,
and the mixtures were incubated at 378C for 30 min. Unaffected PBPs
were labelled with bocillin-FL (5 mM; Invitrogen) at 378C for 30 min. Ali-
quots of these samples, which contained 30 mg of membrane proteins,
were subjected to 8% NuPAGE electrophoresis, using 1× MOPS or 1×
MES buffer and a constant voltage of 90 V. Bocillin-FL fluorescence was
detected with a Typhoon 9410 fluorescence scanner (excitation at
488 nm, detection at 532 nm, high sensitivity, 200 mm resolution) The
amounts of labelled PBPs were quantified by using TIF images with
Bio-Rad Quantity One 4.6.3 software. IC50 values were calculated by
the BioData Fit program (available at http://www.changbioscience.com/
stat/ec50.html).
Specific cefoxitinase assays were carried out as described by
Malouin et al.27
Chromosomal DNA preparation, restriction endonuclease
treatment, PCR and Southern hybridization
Regular restriction endonuclease digestions were performed in a volume
of 20 mL with 0.2–1 mg of DNA under the conditions recommended by
the suppliers. PCR reaction mixtures (usually either 20 or 50 mL) con-
tained half volumes of 2× ReadyMix PCR reaction mix (Sigma), 0.7 mM
primers, 1/10 volume of template DNA and sterile water supplemented
to the indicated final reaction volume. The PCR primer sequences and
the cycling conditions applied are listed in Table S1 (available as Sup-
plementary data at JAC Online). All the PCR experiments started with a
2.5 min starting denaturation at 948C and had a 10 min final elongation
at 728C. Figure 1 outlines the PCR strategy used to detect the cfxA gene
and the structure of MTn4555. The cepA and cfiA genes were detected as
described by Garcı´a et al.22 PCR products or the fragments of the restric-
tion digestion were analysed by 0.7% or 1.2% agarose gel electrophor-
esis, using 0.5 mg/L ethidium bromide and TBE (45 mM Tris-borate/
1 mM EDTA) buffer.
For Southern blotting, PCR products or chromosomal DNA prep-
arations were resolved on 0.7% agarose gels after restriction endonu-
clease treatment of the common 1.2 kb amplified region of MTn4555
(DdeI) or the chromosomal DNA of cfxA-positive strains (Bsu15I), and
were transferred to nylon membranes (Amersham, UK) by capillary
Cefoxitin resistance mechanisms of Bacteroides
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action. Labelling, hybridization and detection were carried out with the
GenImages AlkPhos System (Amersham, UK). The 1.2 kb PCR fragment
of B. fragilis 540/1 amplified with primers cfxA11 and 45D2 was used
for labelled probe preparation.
Inverse PCR and nucleotide sequencing
For inverse PCR, the method of Garcı´a et al.22 was essentially followed.
Chromosomal DNA (0.5 mg) was restricted with BsuRI (HaeIII isoschizo-
mer) enzyme and precipitated with ethanol, and 20 ng of digested DNA
was circularized by T4 ligase [1× T4 ligation buffer, 1.5 mM Co(NH3)6Cl3,
50 mM KCl and 2 U of T4 ligase in a final volume of 50 mL]. Subsequent
PCR amplification was performed as described previously.22
Nucleotide sequencing was carried out as described previously.26 The
sequence data obtained were deposited into GenBank (www.ncbi.nlm.
nih.gov) under accession numbers FJ875532 (B. fragilis 540, 1.2 kb
‘common fragment’) and HQ378596 (upstream region of the cfxA gene
in B. ovatus 32456/2).
Statistical analysis
Thedistributionsof heterogeneous resistanceandnumbersof cfxA-specific
chromosomal DNA fragment copies in the different Bacteroides popu-
lations were compared by means of x2 analysis or the Mann–Whitney
test, using the SPSS program package (SPSS, Inc., Chicago, IL, USA). The
tests were considered significant if the P values were,0.05.
Results
Analysis of random clinical Bacteroides isolates
for the cfxA gene, cefoxitin MIC, cefoxitinase activity
and conjugative transfer of cefoxitin resistance
Eighty-four randomly selected Bacteroides isolates were tested
for their cefoxitin MICs by agar dilution and for the presence of
the cfxA gene by PCR. The rate of resistance (MIC ≥64 mg/L)
was 8.3%. Sixteen cfxA-positive strains (14 B. fragilis, 1
B. ovatus and 1 B. uniformis; 19.0% positivity) were detected
(Table 1). The MIC distribution with respect to the presence of
cfxA is displayed in Figure 2. The MIC range was 1–128 mg/L,
with a shift of the modes of the cfxA-negative and -positive
strains from 8 to 32 mg/L (2-fold dilution), respectively. The pre-
valences of cfxA-positive and -negative strains in the susceptible
category (MICs ≤16 mg/L) were 6.3% and 93.7%, respectively;
those in the resistant category (MICs ≥64 mg/L) were 6.0%
and 2.4%, respectively. Out of the seven resistant strains,
five were cfxA-positive (71.4%). Thus, the cfxA gene had an
effect on the cefoxitin resistance of the strains, but it was only
modest.
In conjugation experiments, the cfxA gene of 9 out of 10
strains could be detected, but only with low frequency
(5.5×1029–3.35×1026/input donor cell) and was not signifi-
cantly affected by tetracycline. The MIC values of cefoxitin for
the transconjugant colonies were determined by the Etest
method (Table 1). These values were 2–3-fold higher, compar-
able to the MIC distribution shift between the cfxA-positive and
-negative strains (2-fold) and the parent strain B. fragilis 638R
(8 mg/L).15
B. vulgatus CLA341 displays a high cefoxitin MIC and a high
cefoxitinase activity (0.359 nmol cefoxitin hydrolysed/mg of
protein/min). For the other examined strains, the hydrolysis of
cefoxitin under the assay conditions was usually within the
range of cefoxitin self-decay.
Cefoxitin affinities of PBP species of selected strains
In order to analyse the roles of PBPs in general and in the over-
lapping cefoxitin MIC distribution for cfxA-negative and -positive
B. fragilis strains, cefoxitin competition assays were carried out,
using both cfxA-negative (n¼11) and cfxA-positive (n¼8)
strains. Strains covering the obtained cefoxitin MIC ranges were
included in order to observe the effect of the PBP affinities on
the MICs; five of the seven resistant strains were also included.
A representative fluorogram is depicted in Figure S1 (available
as Supplementary data at JAC Online) and results are presented
in Table S2 (available as Supplementary data at JAC Online). For
some PBP species (PBP-A and PBP3), the IC50 values were high
(.256 mg/L) and not calculable, because the binding of cefoxitin
was very low and approximately constant in the concentration
range applied (insensitive/low-affinity PBPs). Some PBPs (PBP-D
and PBP4) could not be detected in the majority of strains. The
other PBP species were high-affinity binders. For PBP1ab and
PBP1c, the IC50 values were usually very low and 0.25 mg/L
cefoxitin generally caused full binding. The case for PBP2 was
similar among cfxA-negative strains, but IC50 values could be
calculated; for the cfxA-positive strains, this PBP was often
lacking.
Analysis of the structural variety of MTn4555
The structure of MTn4555 in the 16 cfxA-positive strains from
our random collection was analysed. We identified (i) whether
the cfxA genes are on complete MTn4555 transposons and
(ii) the structures of the regulatory regions of the cfxA genes
(the 3′ regions of MTn4555).
tnpA tnpCint xis orf-5 orf-6 mobA cfxA orf-9/Tpl/ISBf8
alpha
int45-1/2
2.5 kb
tnpA45-1/2 tnpC1/2 xis45-1/2
mobA1/2 cfxA21/22
cfxA11/12
944-1/2
45D1
45D2
gamma
Figure 1. Structure of MTn4555 and the PCR strategy applied. The genes and the ends for MTn4555 are displayed at the top of the figure. At the
bottom of the figure, the PCR fragments amplified from MTn4555 are displayed, with the primer pairs indicated to the left. In the case of the
amplifications with the 45D1 and 45D2 primers, cfxA11 was used as a forward primer.
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All but one of the test strains harboured a complete copy of
MTn4555; with a few exceptions, the 3′ regions of the MTn4555s
displayed a common structure. ISBf8 was detected and mapped
adjacent to the cfxA genes in three strains. For the analysis of
the 3′ regions of MTn4555 transposons, two upstream primer
sequences (45D1 and 45D2; Table S1) were selected to amplify
the region. Primers cfxA11 and 45D2 yielded an 1.2 kb
common sequence for the majority (11 out of 16) of cfxA-positive
strains. Upstream fragments with other sizes (3.0 or 0.7 kb) were
also found. The nucleotide sequence of the 1.2 kb cfxA11-45D2
fragment of B. fragilis 540/1 was determined. Its structure and
sequence are depicted in Figure 3. Comparison of the correspond-
ing sequence of B. vulgatus CLA341 with that of B. fragilis 540/1
demonstrated that there are two insertions in the sequence of
B. vulgatus CLA341; one is ISBf8, and the other is a 360 bp
sequence with terminal direct and inverted repeats. This structure
resembles an IS element, but does not harbour an open reading
frame (ORF). It may therefore belong to the novel and growing
group of miniature transposable elements (MITEs), and was
termed MITEBf2 (Figure S2, available as Supplementary data at
JAC Online). Additionally, the 3′ end of the common 1.2 kb
sequence codedanORF that has not beendocumentedpreviously.
On BLAST searches it exhibited close homology (with scores
between 33.5 and 154, and E-values between 2e-36 and 3e-4)
to a number of cytoplasmic abortive phage infection proteins
(Abis), including species of Bacteroidetes, and it could be aligned
with the lactococcal AbiD proteins (22% identity, 32% homology).
The 1.2 kb cfxA11-45D2 fragments of all strains that yielded them
displayed a common structure and homology after restriction
MIC (mg/L)
1 2 4 8 16 32 64 128
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ns
0
5
10
15
20
25
30
cfxA–
cfxA+
Figure 2. CefoxitinMICdistribution for the cfxA-negative and -positive strains.
Table 1. Characteristics of the cfxA-positive Bacteroides strains from the randomly selected collection
Strain
Cefoxitin MIC (mg/L)
cepA cfxA cfiA ISBf8 MITEBf2 cfxA upa MTn4555b
No. of cfxA
fragmentsc
Conjugationd
agar
dilution Etest Tc2 Tc+ MIC (mg/L)
B. vulgatus CLA341 256 256 NT + NT + + 3.2 C NT ND 4.9×1026 NT
B. fragilis 7979 64 16–(256)e 2 + + + + 3.2 C 3 5.5×1029 ND NT
B. uniformis 32456/1 32 16 2 + 2 + + 3.2 C 2 2.0×1028 ND NT
B. fragilis 6269 32 16 + + 2 + 2 2.9 C 2 3.3×1026 ND 32
B. fragilis 540/1 64 32–(256) + + 2 2 2 1.2 C 6 2.3×1029 3.4×1028 NT
B. fragilis 8887 64 4–(64) + + 2 2 2 1.2 C 7 2.1×1027 ND 64
B. fragilis 66653 64 32 + + 2 2 2 1.2 C 4 1.9×1028 1.0×1027 32
B. fragilis 38470/2 64 32 + + 2 2 2 1.2 C 1 NT NT NA
B. fragilis 724/4 32 32 2 + 2 2 2 1.2 C 5 ND ND NA
B. fragilis 59481 32 16 + + 2 2 2 1.2 C 10 NT NT NA
B. fragilis 13202 32 16 + + 2 2 2 1.2 C 4 NT NT NA
B. fragilis 427/31 32 16 2 + 2 2 2 1.2 C 1 ND 1.9×1029 64
B. fragilis 84219/4 16 16 + + 2 2 2 1.2 C 4 4.6×1029 ND 64
B. fragilis 59483 16 16 2 + 2 2 2 1.2 C 5 NT NT NA
B. fragilis 84219/2 16 8 + + 2 2 2 1.2 C 3 NT NT NA
B. fragilis 71928/4 32 16–(64) + + 2 2 2 0.7 C 3 1.4×1028 1.8×1028 64
B. ovatus 32456/2 4 2 2 + 2 2 2 NA cfxA 2 NT NT NA
NT, not tested; ND, not detected; NA, not applicable.
aThe sizes of PCR fragments obtained by the cfxA11 and 45D2 primers.
bC denotes that complete copies of MTn4555 were found, while cfxA denotes that, using PCR, products could only be obtained using the cfxA21/22
primer pair.
cThe numbers of the detected cfxA-hybridizing chromosomal fragments are shown.
dThe frequencies of cefoxitin resistance transfer are displayed, expressed as the number of transconjugants per input donor cell. The MICs for the
transconjugant isolates recorded by Etests are displayed. Tc+, tetracycline induction; Tc2, no tetracycline induction.
eIn the heterogeneous resistance readings, the first number denotes the value for even growth, while the number in parentheses denotes the value
where the separate colonies disappeared.
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digestion (DdeI) and Southern blotting (data not shown). Primers
cfxA11 and 45D1 amplified 2.8 kb fragments in two test strains.
Since primer45D1 fell into the sequenceofMITEBf2, itwaspossible
to detect this element independently. The exception to the strains
carrying full copies of MTn4555 was B. ovatus 32456/2, which had
only the cfxA region. For this strain, the upstream sequence of the
10        20        30        40     50        60        70        80 
AACTACGATTTGTTTTTTTCTGTTTTTTTCCATGTTTATATTATTTATATTTGTTTGACGAGAATATCTTTATTTGCCGA
CAAAGGTACATAACTTTACGGAAAAATATGTTTCTAAAATATATAAATAGACAGCTGTGGGGAAAATGTGGGGAAAAATT
                  ->        -> 
AGATAATTAAAAAGGCTAAATGACTGGAAATAATCACTTAGCCTTTTAATCCGTACCCAGACCCGTACTTCGTAATTGCT
             M  M  P  M  R  M  P  N  T  W  I 
GCGCCCATCATTCAAGACTGTCAAATCGGGTCTTTCCTGTCAAGCCAATGATGCCTATGCGTATGCCAAACACATGGATT
T  D  F  S  F  R  E  Q  T  L  Y  P  Q  L  C  Y  V  V  Y  W  L  N  S  I  S  M  G 
ACGGATTTCTCGTTCCGTGAACAAACACTTTATCCGCAACTCTGCTATGTGGTGTATTGGCTTAACTCCATTTCTATGGG
 N  T  F  V  A  D  F  K  Q  L  L  S  K Y  P  S  V  R  T  R  L  L  G  F  P  H  N 
CAACACTTTTGTTGCAGATTTCAAGCAGCTTTTATCGAAATAcCCATCAGTAAGAACTCGTTTATTAGGCTTTCCTCATA
  W  E  Q  E  P  L  W  R  * 
ATTGGGAACAAGAGCCTTTGTGGAGATAAAATAATTGCCCTGTTTCTTAAAAAGCACTGGGGCAAACCAGCTCCGTCTTT
Figure 3. Nucleotide sequence of the characteristic part of the common 1.2 kb regulatory region of the cfxA gene with the Abi protein ORF. The amino
acid sequence of the Abi protein is displayed above the first nucleotides of its codons. The start codon of the cfxA gene is in italic+bold and the
proposed promoter sequence for abiD is underlined+bold. The detected mutations of the region, the insertions of ISBf8 and MITEBf2, and the
deletions are marked with underlining and stems of arrows, respectively.
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Figure 4. Characteristics of heterogeneously cefoxitin-resistant strains. Appearance of the resistance patterns using cefoxitin Etests for a
cfxA-negative strain (B. thetaiotaomicron S21) (a) and for a cfxA-positive strain (B. fragilis 53148) (b). Population analysis profiles for cefoxitin (c).
FOX, cefoxitin.
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cfxA gene was determined after an inverse PCR (Figure S3, avail-
able as Supplementary data at JAC Online).
Analysis of cefoxitin-heteroresistant strains; copy
number determination of the cfxA genes
in both sets of strains
Our studies to detect the efficacy of common anti-Bacteroides
agents revealed strains with very high or heterogeneous resist-
ance in cefoxitin Etests (11 of 280; 3.9%) (Figure 4a and b).
These strains were subjected to the same molecular analysis as
the 17 cfxA-positive Bacteroides; the molecular data are listed in
Table 2. Out of the 11 strains, 7 were positive for cfxA. The PAPs
were determined for three representative strains: one susceptible
strain with homogeneous phenotype, B. thetaiotaomicron 53127;
one heterogeneously resistant without a cfxA gene, B. thetaiotao-
micron S21; and one heteroresistant with a cfxA gene, B. fragilis
24381 (Figure 4c). This experiment confirmed that strains with
heterogeneous resistance in Etests also demonstrated hetero-
geneous resistance in PAP (compare two strains in Table 2 and
Figure 4c). After this observation, we also conducted Etests on
the strains with cfxA genes from the random collection to see
whether there were heteroresistant strains among them; three
such strains were found. The most prominent molecular feature
of the cfxA-positive cefoxitin-heteroresistant strains was the
accumulation of mutations in the 3′ region of MTn4555
(Figure 3). The difference between the proportion of heteroresis-
tant strains having the ‘basic’, 1.2 kb region (3/12, 25.0%) and
those with mutation (8/11, 72.7%) was statistically significant
(P¼0.03) among the strains with cfxA genes. The mutations
might affect the expression of the AbiD encoded in this region
by inhibiting its transcription (see the promoter sequence
upstream; Figure 3). To relate the resistance levels and the mol-
ecular characteristics of the MTn4555 elements, copy numbers
in individual cfxA-positive strains were determined by Southern
blotting [Figure S4 (available as Supplementary data at JAC
Online) and Tables 1 and 2]. Besides the heteroresistant strains
having more mutations in the regulatory region, they exhibited
a tendency to have fewer copies of the cfxA gene.
Discussion
In this study, we investigated the roles of PBPs and the CfxA
cephamycinase in the cefoxitin resistance of Bacteroides
strains. The genetic element MTn4555, harbouring the cfxA
gene, was also characterized. The prevalence of the cfxA gene
among Hungarian clinical isolates was found to be 19%, a
value in the range determined previously.22,28–30 The preva-
lences of the cfxA gene in Brazil among all Bacteroides and
B. fragilis strains, and all Bacteroides in Spain were 15.1%,
12.0% and 27.3%, respectively. Our results demonstrated that,
with a nomenclature proposed previously, the PBP-A and PBP3
species are weak binders of cefoxitin (the IC50 values were
usually .256 mg/L), whereas the others (PBP1ab, PBP1c and
PBP2) can be inhibited at very low concentrations (,1 mg/L).
This phenomenon indicates that insensitive PBPs are good candi-
dates in the development of high cefoxitin MICs experienced fre-
quently in this and in other studies and the PBP affinity results
indicate a balanced action of PBPs under antibiotic stress—the
insensitive ones can undertake the role of peptidoglycan syn-
thesis of the sensitive ones ensuring high MIC values, but the
inhibition of the sensitive ones decreases the possibility of attain-
ing high MICs. In previous studies of the effects of cephalosporins
on the antibiotic resistance levels of different Bacteroides species,
similar molecular weight PBPs were detected, but the effect of
cefoxitin was not well elucidated. Yotsuji et al.12 detected PBPs
with molecular weights of 94 (1a), 90 (1b), 88 (1c), 82 (2) and
72 (3) kDa, and correlated the benzylpenicillin competition of
Table 2. Characteristics of the heterogeneously cefoxitin-resistant Bacteroides strains
Strain
Cefoxitin MIC (mg/L)
cepA cfxA cfiA ISa cfxA (kbp)b No. of cfxA fragmentscagar dilution Etest
B. fragilis 53148 256 8–(256)d + 2 2
B. fragilis 5269 256 256 + + 2 2 0.5 2
B. fragilis 34581/2 64 64–(256) 2 + 2 ISBf8, MITEBf2 3.2 2
B. fragilis 13405 32 32–(256) + 2 2
B. fragilis D46 32 16–(256) + + 2 2 ND 1
B. fragilis D34 16 8–(256) + 2 2
B. fragilis 76240 NT 128–(256) + + 2 IS614B NT 3
B. thetaiotaomicron 53127 256 32–(128) 2 + 2 ISBf8, MITEBf2 3.2 2
B. thetaiotaomicron S21 256 32–(256) 2 2 2
B. thetaiotaomicron 85395 256 16–(64) 2 + 2 ISBf6 2.9 2
B. fragilis D21 NT .256 2 + 2 2 1.2 3
ND, not detected; NT, not tested.
aFor the cfxA-positive strains, the absence (2) or presence of specific insertion elements is displayed.
bThe sizes of PCR fragments obtained with the cfxA11 and 45D2 primers.
cThe numbers of the detected cfxA-hybridizing chromosomal fragments are shown.
dIn the heterogeneous resistance readings the first number denotes the value for even growth, while the number in parentheses denotes the value
where the separate colonies disappeared.
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five cephalosporins with their MICs. Although that study
detected mainly the same PBPs as the present study, cefoxitin
was not included; however, the PBPs designated 1b, 1c, 2 and
3 (1ab, 1c, 2 and 3 according to our nomenclature) were also
very susceptible to cefoperazone. A similar PBP pattern was
detected by Piddock and Wise,13 except that the 94 kDa
PBP-A (or PBP1a according to Yotsuji et al.12) was not investi-
gated in great detail. However, this latter protein was barely
visible in competition assays with benzylpenicillin. Fang et al.11
focused on competition assays of piperacillin and cefoxitin with
biotinylated ampicillin in mutants selected for cefoxitin resist-
ance. They detected increased IC50 values of PBPs with molecu-
lar weights of 86 and 72 kDa for these antibiotics as compared
with the parent B. thetaiotaomicron 238 strain.11 However, we
used only B. fragilis strains, since accurate PBP detection was
available both by antibiotic labelling and genomic data. No
appreciable difference was observed between the IC50 values
for the cfxA-positive and -negative strains, except for the relative
lack of PBP2 among the cfxA-positive strains. However, it would
be better to examine the IC50 values of the insensitive PBPs
above 256 mg/L and use not only membrane preparations but
undertake the laborious task of measuring the cefoxitin affinities
of purified PBPs (such studies have been initiated in our labora-
tories for PBP-A). No examination was carried out on differences
in the outer membrane permeability among our tested strains.
However, the outer membrane protein loss linked to the cefoxitin
resistance of Bacteroides has only been detected in some
selected highly resistant isolates,31 whereas the role of efflux
pumps has been demonstrated for fluoroquinolones and for
other b-lactams, but not for cefoxitin.32 Interestingly, the pres-
ence of the cfxA gene did not greatly elevate the cefoxitin
MICs for the carrying strains as compared with the cfxA-negative
strains; the increase was 2-fold after the conjugation and
between the cfxA-positive and -negative strains. These data
invoke the previously mentioned high basal level resistance and
inefficient hydrolysis of cefoxitin by CfxA. In accordance with
this, the cefoxitin decay by CfxA has been given as ,0.01% rela-
tive to that of cefaloridine.15 The high cefoxitinase production by
B. vulgatus CLA341 can be explained by the increase in the copy
number of MTn4555 (our unpublished preliminary results). This
control strain differed from the examined strains in other
aspects too: the conjugal transfer of its cfxA gene was very effi-
cient and was inducible by a low level of tetracycline. The
phenomenon that tetracycline conjugative transposons, such
as CTnDOT and CTnERL, are inducible by tetracycline as regards
the tetracycline resistance levels and their conjugative transfer
efficiencies, has long been known, and the regulatory mechanism
behind it was examined extensively. As helper elements, they can
also mobilize co-resident plasmids and mobilizable transposons,
e.g. MTn4555.33 However, the conjugation frequency is not
always high and is not always inducible by tetracycline. A specific
region is responsible for this in the above-mentioned conjugative
transposons, as was demonstrated recently.34 We presume that
there was no conjugative helper element in some of our strains
or that the above-mentioned regulatory region was lacking
from the CTns of these strains. These data imply a lesser spread
than expected of the cfxA-mediated resistance mechanism
among Bacteroides strains.
We described heterogeneously cefoxitin-resistant strains.
Heterogeneous antibiotic resistance is best known for methicillin-
resistant Staphylococcus aureus (MRSA),35 penicillin-resistant
Streptococcus pneumoniae36 and carbapenem-resistant Pseudo-
monas aeruginosa.37 In the case of MRSA strains, a low-affinity
PBP (PBP2a or PBP2′) is the primary resistance determinant,
which is encoded on a specific chromosomal resistance island,
SCCmec,38 and some auxiliary chromosomal genes (fem or
aux) are also necessary for this resistance phenotype to
develop. The role of these latter genes is to produce altered
substrates during cell wall synthesis.35 In the case of cefoxitin
heteroresistance among Bacteroides, the role of the insensitive
or low-affinity PBPs can also be expected, as for MRSA.
The 3′ region of the MTn4555 elements, which is a regulatory
region for the cfxA gene, displayed diversity. The strains from our
random collection had moderate cefoxitin MICs, and most of
them had a common 1.2 kb region at the 3′ end and harboured
an ORF for AbiD. Themodification of this region was characterized
by insertional (ISBf8, IS614B and MITEBf2) or deletion mutations.
The role of AbiD is to inhibit the intracellular replication of invading
phages and mobile elements by cleavage of their replicative
forms.39 It is interesting, as compared with B. vulgatus CLA341,
for which we expect a copy number increase behind the high
level of cefoxitinase production and resistance, that the heterore-
sistant strains more frequently had lower copy numbers of cfxA
genes and mutations at the 3′ end of the MTn4555 elements
(Mann–Whitney U-test, P¼0.005). From these data we hypoth-
esize that MTn4555 increases its copy number in the case of
highly resistant colonies of the heteroresistant strains, because
of the lack of AbiD. Such copy number elevations are not rare in
the development of antibiotic resistance and may be a cause of
emerging antibiotic resistance.40,41 Garcı´a et al.22 also found a
high level of variability in the 3′ regulatory region of MTn4555
among Bacteroides strains from Spain, where the prevalence of
cfxA is quite high (see above). They could correlate the
b-lactamase production and the structure of this 3′ regulatory
region, where the presence of IS614B made the strains high
b-lactamase producers.22 In one of our strains, we also found an
insertion of IS614B into the upstream region of cfxA (B. fragilis
76240 with a very high level of cefoxitin resistance; Table 2).
Thus, further studies are needed to clarify the contributions of
cfxA copy number and different promoter regions to the overall
cefoxitinase production.
We can conclude that the molecular examination of MTn4555
and the PBP affinity measurements was a start to better under-
stand the cefoxitin resistance of Bacteroides species caused by
multiple factors. According to our results, we hypothesize that
PBPs play a major role and that cfxA expression is only a minor
factor, noting (i) the IC50 values of .256 mg/L for PBP-A and
PBPBf4, and (ii) the 2-fold increase in the MICs for the transcon-
jugants and cfxA-positive strains and the low cefoxitinase activity
of CfxA. The interaction of these two resistance mechanisms is
obvious but the exact nature of this interaction remains to be
determined. This interaction may be simply additive but may
be regulated in more complex ways giving rise to bi- or multi-
stable states accounting for the heteroresistance experienced.
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